Copyright
©The Author(s) 2023.
World J Clin Cases. Nov 6, 2023; 11(31): 7610-7618
Published online Nov 6, 2023. doi: 10.12998/wjcc.v11.i31.7610
Published online Nov 6, 2023. doi: 10.12998/wjcc.v11.i31.7610
Group | CD3+ (%) | t | P value | CD4+ (%) | t | P value | CD8+ (%) | t | P value | |||
Pre-treatment Post-treatment | Post-treatment Post-treatment | Pre-treatment Post-treatment | Post-treatment Post-treatment | Pre-treatment Post-treatment | Post-treatment Post-treatment | |||||||
Observation group (n = 65) | 44.6 ± 6.34 | 67.4 ± 4.65 | -8.25 | 0.008 | 29.8 ± 5.56 | 42.8 ± 5.06 | -9.78 | 0.011 | 33.2 ± 5.21 | 25.6 ± 4.89 | 10.6 | 0.012 |
Control group (n = 65) | 44.7 ± 7.32 | 58.8 ± 5.63 | -2.67 | 0.004 | 28.3 ± 5.25 | 38.9 ± 7.48 | -8.96 | 0.012 | 32.7 ± 6.18 | 28.5 ± 5.12 | 9.78 | 0.023 |
t | 1.785 | 2.165 | 0.895 | 2.418 | 0.794 | 0.947 | ||||||
P value | 0.562 | 0.024 | 0.732 | 0.002 | 0.001 | 0.003 |
- Citation: Cao JY, Wang YC, Deng XX. Efficacy of β2-adrenergic receptor agonist combined with corticosteroid in the treatment of children with cough variant asthma. World J Clin Cases 2023; 11(31): 7610-7618
- URL: https://www.wjgnet.com/2307-8960/full/v11/i31/7610.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i31.7610